PMID: 6400668May 1, 1983Paper

Diabetic nephropathy. A perspective

Diabetes
S M MauerD M Brown

Abstract

The earliest manifestations of clinical diabetic nephropathy, including proteinuria, hypertension, and declining GFR, represent very advanced diabetic glomerulopathy with especially prominent mesangial expansion. Mesangial expansion, by restricting glomerular capillary filtration surface and lumenal volume, stimulates compensatory mechanisms analogous to those resulting from a marked reduction in nephron number. These compensatory mechanisms involve alterations in glomerular hemodynamics designed to maintain glomerular filtration but which ultimately injure the kidney. These hemodynamic perturbations are not specific to diabetes but represent a final common pathway toward endstage renal failure that also characterizes the remnant kidney. This thesis concludes that the onset of clinical diabetic nephropathy augurs inevitable decline in kidney function, and that only studies and interventions exercised before clinical nephropathy develops can influence understanding and outcome of diabetic nephropathy.

Citations

Apr 14, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Torun Birgitta TorbjörnsdotterUlla Birgitta Berg
Oct 1, 1984·Annals of Surgery·D E SutherlandJ S Najarian
Dec 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R Rasch, P Holck
Nov 14, 1997·The Journal of Small Animal Practice·P A GrahamQ A McKellar
Dec 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J A Breyer
Nov 1, 1986·The Anatomical Record·E C Carlson, K K Surerus
Mar 1, 1988·The American Journal of Physiology·H J ArnqvistG L King
May 19, 1988·The New England Journal of Medicine·M BrownleeH Vlassara

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.